Kestra Advisory Services’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-843
Closed -$68.4K 3839
2025
Q4
$68.4K Buy
+843
New +$72.6K ﹤0.01% 3727

Other funds holding LMAT

Kestra Advisory Services's LMAT Position: Q1 2026 in Review

Kestra Advisory Services sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 843 shares — an estimated $68.4K sold.

Kestra Advisory Services first reported a position in LMAT in Q4 2025 and held it in 1 quarter. The position peaked at $68.4K in Q4 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Kestra Advisory Services reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 843 LeMaitre Vascular shares in Q1 2026, an estimated $68.4K.
  • Kestra Advisory Services first reported a position in LeMaitre Vascular in Q4 2025 and held it in 1 quarter.
  • Kestra Advisory Services's LeMaitre Vascular position peaked at $68.4K in Q4 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.